YPhos is a class of functionalized phosphine compounds featuring ylide functional groups. An ylide is a neutral molecule characterized by adjacent atoms bearing formal positive and negative charges, typically involving phosphorus and carbon atoms. These compounds are synthesized by reacting a phosphine with an alkyl halide to form a phosphonium salt, followed by deprotonation of the salt with a strong base to yield the ylide.
Professor Viktoria H. Gessner's group at Ruhr University Bochum developed a class of ylide-substituted phosphine compounds (YPhos), whose structures contain an ylide substituent directly bonded to the phosphorus atom, as shown in Figure 1. The preparation of YPhos is straightforward: reaction of a phosphine with an alkyl halide yields a phosphonium salt, which upon subsequent deprotonation with a strong base forms the YPhos ligand, as illustrated in Figure 2.
YPhos ligands are electron-rich, enabling palladium-catalyzed coupling reactions under very mild conditions. Both keYPhos and joYPhos exhibit good activity in Buchwald-Hartwig amination reactions at room temperature. Professor Gessner's mechanistic study in 2020 confirmed that, compared to CyJohnPhos and P(tBu)₃, keYPhos readily forms low-coordinate palladium complexes. This facilitates oxidative addition, subsequent amine coordination, and reductive elimination. The P-C-P angle in keYPhos can adapt to the metal's coordination environment, allowing the ligand to maintain its conformation throughout the catalytic cycle. This enables the efficient coupling of aryl chlorides with amines at room temperature, as depicted in Figure 3.
YPhos ligands have achieved the palladium-catalyzed α-arylation of alkyl ketones with aryl chlorides, demonstrating record-breaking activity, as shown in Figure 4. The keYPhos ligand efficiently facilitates the monoarylation of various challenging ketone substrates under mild conditions. The trYPhos ligand also shows high activity in this reaction. The practicality of this synthetic method is demonstrated by gram-scale reactions and the synthesis of ε-caprolactone derivatives.
In 2023, Professor Gessner reported a Pd/YPhos-catalyzed arylation of N-protected hydantoins with aryl chlorides, as shown in Figure 5. This strategy enables selective monoarylation, tandem diarylation, and arylative alkylation sequences. A stepwise deprotection strategy provides a shortcut for synthesizing hydantoin derivatives. Notably, this method can also be used to synthesize derivatives of the anticonvulsant drugs phenytoin and mephenytoin.
A method for constructing partially and fully unsymmetrical tertiary phosphines via Pd/keYPhos-catalyzed coupling of aryl chlorides with secondary phosphines was developed. This reaction exhibits excellent functional group tolerance and a broad substrate scope. Furthermore, the rapid synthesis of ligands and luminescent compounds (sTPPs), along with gram-scale synthesis, demonstrates the utility of this method, as illustrated in Figure 6.
In 2025, the research groups of Prof. Yu Lin and Prof. Duan Wengui at Guangxi University proposed a mild and efficient method for the arylation of N–H heteroarenes using a low-loading Pd/keYPhos catalyst (0.8 mol%), as shown in Figure 7. This method employs inexpensive and structurally diverse aryl chlorides as electrophiles to react with indoles, pyrroles, and carbazoles, enabling the construction of various N-arylated products. The method features excellent functional group tolerance and is suitable for gram-scale synthesis. Moreover, the relatively inert Ar–Cl bond allows for late-stage functionalization of drugs and stepwise coupling reactions, providing a complementary strategy for the N-arylation of N–H heteroarenes.
In summary, YPhos ligands exhibit outstanding performance in palladium-catalyzed coupling reactions, enabling highly efficient couplings under mild conditions, and represent a class of increasingly mature and privileged ligands.
References:
- ACS Catal. 2020, 10, 999–1009
- Chem. Eur. J. 2020, 26, 4281–4288
- Org. Lett. 2019, 21, 7558–7562
- ACS Catal. 2023, 13, 6846–6850
- Org. Lett. 2024, 26, 10564–10569
- Org. Biomol. Chem. 2025, 23, 1581–1587